Detection of antimicrobial resistance by small rural hospital microbiology laboratories: Comparison of survey responses with current NCCLS laboratory standards

Diagnostic Microbiology and Infectious Disease

Volumn 47, Issue 1, 2003, Pages 303-311

  Stevenson, Kurt B ^a,b   Samore, Matthew ^b   Barbera, James ^a   Moore, James W ^a   Hannah, Elizabeth ^a   Houck, Peter ^c   Tenover, Fred C ^d   Gerberding, Julie L ^d  

^a QUALIS HEALTH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Centers for Medicare and Medicaid Services   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; METICILLIN; PENICILLIN G; VANCOMYCIN;

ACCURACY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; COMMUNICABLE DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; ENTEROBACTERIACEAE; ENTEROCOCCUS; ENZYME INDUCTION; GRAM NEGATIVE BACTERIUM; HEALTH SURVEY; HOSPITAL LABORATORY; HUMAN; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TEST; NONHUMAN; PENICILLIN RESISTANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RELIABILITY; RURAL HEALTH CARE; SCREENING TEST; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VALIDATION PROCESS;

EID: 0041827162     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(03)00092-0     Document Type: Article

References (41)

1. Arason V.A., Kristinsson K.G., Sigurdsson J.A., Stefansdottir G., Molstad S., Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ. 313:1996;387-391.
2. Booth A.L., Weeks R.M., Hutcheson R.H., Schaffner W. A statewide characterization of hospital infection control practices and practitioners. Infect Control. 1:1980;227-232.
3. Boyce J.M. Consequences of inaction importance of infection control practices . Clin Infect Dis. 33:2001;S133-S137.
4. Britt M.R. Infectious diseases in small hospitals. Prevalence of infections and adequacy of microbiology services. Ann Intern Med. 89:1978;757-760.
5. Britt M.R., Burke J.P., Nordquist A.G., Wilfert J.N., Smith C.B. Infection control in small hospitals-prevalence surveys in 18 institutions. JAMA. 236:1976;1700-1703.
6. Laboratory capacity to detect antimicrobial resistance. MMWR. 48:2000;1167-1170.
7. Assessment of susceptibility testing practices for Streptococcus pneumoniae - United States, February 2000. MMWR. 51:2002;392-394.
8. Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR. 51:2002;565-567.
9. Doern G.V., Brueggemann A.B., Pfaller M.A., Jones R.N. Assessment of laboratory performance with Streptococcus pneumoniae antimicrobial susceptibility testing in the United States. Arch Pathol Lab Med. 123:1999;285-289.
10. Fridkin S.K. Vancomycin-intermediate and -resistant Staphylococcus aureus what the infectious diseases specialist needs to know . Clin Infect Dis. 32:2001;108-115.
11. Fridkin S.K., Edwards J.R., Tenover F.C., Gaynes R.P., McGowan J.E. Jr. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Clin Infect Dis. 33:2001;324-330.
12. Fridkin S.K., Steward C.D., Edwards J.R., Pryor E.R., McGowan J.E. Jr., Archibald L.K., Gaynes R.P., Tenover F.C. Surveillance of antimicrobial use and antimicrobial resistance in United States Hospitals Project ICARE Phase 2 . Clin Infect Dis. 29:1999;245-252.
13. Gerding D.N., Larson T.A., Hughes R.A., Weiler M., Shanholtzer C., Peterson L.R. Aminoglycoside resistance and aminoglycoside usage ten years of experience in one hospital . Antimicrob Agents Chemother. 35:1991;1284-1290.
14. Goldmann D.A., Huskins W.C. Control of nosocomial antimicrobial-resistant bacteria A strategic priority for hospitals worldwide . Clin Infect Dis. 24:(Suppl):1997;S139-S145.
15. Goldmann D.A., Weinstein R.A., Wenzel R.P., Tablan O.C., Duma R.J., Gaynes R.P., Schlosser J., Martone W.J. Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership [see comments]. JAMA. 275:1996;234-240.
16. Haley R.W., Culver D.H., White J.W. The efficacy of infection surveillance and control programs in preventing nosocomial infections in U. S. hospitals. Am J Epidemiol. 121:1985;182-205.
17. Jones R.N. Method preferences and test accuracy of antimicrobial susceptibility testing. Updates from the college of American Pathologists Microbiology Surveys Program 2000. Arch Pathol Lab Med. 125:2001;1285-1289.
18. Kristinsson K.G. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb Drug Resist. 3:1997;117-123.
19. Lawton R.M., Fridkin S.K., Gaynes R.P., McGowan J.E. Jr. Practices to improve antimicrobial use at 47 US hospitals The status of the 1997 SHEA/IDSA position paper recommendations . Infect Control Hosp Epidemiol. 21:2000;256-259.
20. McGowan J.E. Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis. 5:1983;1033.
21. McGowan J.E. Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol. 15:1994;478-483.
22. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Graw Aerobically. Approved Standard M7-A5. 2000;National Committee for Clinical Laboratory Standards, Wayne, PA.
23. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard M2-A7. 2000;National Committee for Clinical Laboratory Standards, Wayne, PA.
24. Performance standards for antimicrobial susceptibility testing; M100-S11. 2001;National Committee for Clinical Laboratory Standards, Wayne, PA.
25. Analysis and presentation of cumulative antimicrobial susceptibility testing data; proposed guideline, M39-P. 1. 2002;National Committee for Clinical Laboratory Standards, Wayne, PA.
26. Paterson D.L., Ko W.C., Von Gottberg A., Casellas J.M., Mulazimoglu L., Klugman K.P., Bonomo R.A., Rice L.B., McCormick J.G., Yu V.L. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases Implications for the clinical microbiology laboratory . J Clin Microbiol. 39:2002;2206-2212.
27. Peterson L.R., Hamilton J.D., Baron E.J., Tompkins L.S., Miller J.M., Wilfert C.M., Tenover F.C., Thomson R.B. Jr. Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of heath care. Clin Infect Dis. 32:2001;605-611.
28. Richet H.M., Mohammed J., McDonald L.C., Jarvis W.R. Building communication networks International network for the study and prevention of emerging antimicrobial resistance . Emerging Infectious Disease. 7:2001;319-322.
29. Ricketts, T. C., Johnson-Webb, K. D. , Taylor, P. (1998). Definitions of rural: A Handbook for Health Policy Makers and Researchers. Washington DC, Federal Office of Rural Health Policy, Health Resources and Services Administration, US DHHS.
30. Ricketts T.C.I., Heaphy P.E. Hospitals and rural America. West J Med. 173:2000;418-422.
31. Scheckler W.E. Hospital epidemiology and infection control in small hospitals. Mayhall C.G. Hospital Epidemiology and Infection Control. 1996;1147-1151 Williams and Wilkins, Baltimore.
32. Scheckler W.E., Peterson P.J. Nosocomial infection prevalence, risk and control in small community and rural hospitals. Infect Control. 7:1986;144-148.
33. Scheckler W.E., Peterson P.J. Nosocomial infections in 15 rural Wisconsin hospitals-results and conclusions from 6 months of comprehensive surveillance. Infect Control. 7:1986;397-402.
34. Shlaes D.M., Gerding D.N., John J.F. Jr, Craig W.A., Bornstein D.L., Duncan R.A., Eckman M.R., Farrer W.E., Greene W.H., Lorian V., Levy S., McGowan J.E. Jr, Paul S.M., Ruskin J., Tenover F.C., Watanakunakorn C. Society for Healthcare Epidemiology and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance Guidelines for the prevention of antimicrobial resistance in hospitals . Clin Infect Dis. 25:1997;584-599.
35. Smith T.L., Pearson M.L., Wilcox K.R., et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med. 340:1999;493-501.
36. Steward C.D., Wallace D., Hubert S.K., Lawton R., Fridkin S.K., Gaynes R.P., McGowan J.E. Jr, Tenover F.C. Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of ICARE laboratories. Diagn Microbiol Infect Dis. 38:2000;59-67.
37. Tenover F.C. Development and spread of bacterial resistance to antimicrobial agents An overview . Clin Infect Dis. 33:2001;S108-S115.
38. Tenover F.C., Lancaster M.V., Hill B.C., Steward C.D., Stocker S.A., Hancock G.A., O'Hara C., McCallister S.K., Clark N.C., Hiramatsu K. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol. 36:1998;1020-1027.
39. Tenover F.C., Mohammed M.J., Gorton T.S., Dembek Z.F. Detection and reporting of organisms producing extended-spectrum β-lactamases survey of laboratories in Connecticut . J Clin Microbiol. 37:1999;4065-4070.
40. Tenover F.C., Mohammed M.J., Stelling J., O'Brien T., Williams R. Ability of laboratories to detect emerging antimicrobial resistance Proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibillity testing . J Clin Microbiol. 39:2001;241-250.
41. Tenover F.C., Swenson J.M., O'Hara C., Stocker S.A. Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J Clin Microbiol. 33:1995;1527.